Bessler W G, Kleine B, Martinez Alonso C, Biesert L, Strecker M, Wiesmüller K H, Metzger J, Jung G
Institut für Immunbiologie der Universität, Freiburg, Federal Republic of Germany.
Lung. 1990;168 Suppl:707-15. doi: 10.1007/BF02718197.
Bacterial extracts obtained from pathogenic strains occurring in lung infections (Broncho Vaxom) or urogenital infections (Urovaxom) as well as defined surface components of Gram-negative bacteria purified from bacteria or obtained by chemical synthesis were tested for their immunomodulatory properties in a murine system. The bacterial extracts were able to act as immunogens inducing an antigen-specific response. Both the bacterial extracts and the purified bacterial cell wall components constituted polyclonal activators of murine splenic B cells, as demonstrated by proliferation assays measuring the incorporation of [3H]thymidine into DNA. They were also able to act as immunoadjuvants increasing the SRBC and the BSA-TNP specific immune response, and could induce tumor cytotoxicity in bone marrow-derived macrophages. The results show that bacterial extracts and defined bacterial surface components constitute immunogens as well as immunomodulators in vitro and in vivo.
从肺部感染(支气管疫苗)或泌尿生殖系统感染(泌尿疫苗)中分离出的致病菌株获得的细菌提取物,以及从细菌中纯化或通过化学合成获得的革兰氏阴性菌特定表面成分,在小鼠系统中进行了免疫调节特性测试。这些细菌提取物能够作为免疫原诱导抗原特异性反应。通过测量[3H]胸苷掺入DNA的增殖试验表明,细菌提取物和纯化的细菌细胞壁成分均构成小鼠脾脏B细胞的多克隆激活剂。它们还能够作为免疫佐剂增强对绵羊红细胞(SRBC)和牛血清白蛋白-三硝基苯(BSA-TNP)的特异性免疫反应,并能在骨髓来源的巨噬细胞中诱导肿瘤细胞毒性。结果表明,细菌提取物和特定的细菌表面成分在体外和体内均构成免疫原以及免疫调节剂。